Información a pacientes: cuándo y qué información suministrar.
Saved in:
| Title: | Información a pacientes: cuándo y qué información suministrar. |
|---|---|
| Alternate Title: | Patient information: what type and when should it be provided? |
| Authors: | Frutos, Miguel Ángel1 mangel.frutos.sspa@juntadeandalucia.es, Cabello, Mercedes1 |
| Source: | Nefrologia. 2010, Vol. 30 Issue S2, p39-46. 8p. 1 Color Photograph, 1 Chart, 1 Graph. |
| Subjects: | KIDNEY transplantation, QUALITY of life, MEDICAL informatics, MEDICAL records, NEPHROLOGY, MEDICAL ethics, ORGAN donors |
| Abstract (English): | The living donor kidney transplant should be considered a priority option providing better quality of life and survival for those needing renal replacement therapy. To increase their number, both nephrologists and patients, should be informed more and better, offering this option compared with LDKT alternatives (dialysis or kidney transplant from a deceased donor). The clinical nephrology consultations or specific pre-dialysis are the space where in stages 3 and 4 of renal failure should be started on LDKT informational approaches. Later, when seeking more detailed information and/or evaluation of potential donors, this could be provided at times and spaces specifically reserved for awareness professionals with the use of brochures or Internet addresses. Information should focus especially on the additional benefits of pre-emptive LDKT, the risks of nephrectomy and long term controls for the donor. Finally, donor, recipient and family should know that the donation will only be justified and may be accepted if the studies of risk/benefit for the donor and recipient have been faithfully evaluated according to the highest ethical standards. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | El trasplante renal de donante vivo (TRDV) se debe ofrecer como opción terapéutica prioritaria porque proporciona mejores resultados en calidad de vida y supervivencia para quienes precisan tratamiento renal sustitutivo. Para aumentar su número, es preciso informar más y mejor, tanto a nefrólogos como a pacientes, ofreciendo la opción del TRDV junto a las alternativas de tratamiento con diálisis o trasplante renal de donante fallecido. Las consultas de nefrología clínica o las específicas de prediálisis son el espacio donde en estadios 3 y 4 de insuficiencia renal se deben iniciar planteamientos informativos sobre TRDV. Posteriormente, caso de solicitar información más detallada y/o valoración de potenciales donantes, ésta se podría facilitar en momentos y espacios específicamente reservados por profesionales concienciados, siendo de ayuda la utilización de folletos informativos o direcciones de Internet. La información debería incidir especialmente en los beneficios adicionales del TRDV anticipado, los riesgos que supone la intervención de nefrectomía, y los cuidados y controles que necesitará el donante. Finalmente, donante, receptor y familiares deben saber que la donación sólo estará justificada, y podrá ser aceptada, si los estudios de riesgo/beneficio para donante y receptor han sido fielmente evaluados de acuerdo a los mejores estándares éticos. [ABSTRACT FROM AUTHOR] |
| Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | MedicLatina |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: lth DbLabel: MedicLatina An: 57085580 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Información a pacientes: cuándo y qué información suministrar. – Name: TitleAlt Label: Alternate Title Group: TiAlt Data: Patient information: what type and when should it be provided? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Frutos%2C+Miguel+Ángel%22">Frutos, Miguel Ángel</searchLink><relatesTo>1</relatesTo><i> mangel.frutos.sspa@juntadeandalucia.es</i><br /><searchLink fieldCode="AR" term="%22Cabello%2C+Mercedes%22">Cabello, Mercedes</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Nefrologia%22">Nefrologia</searchLink>. 2010, Vol. 30 Issue S2, p39-46. 8p. 1 Color Photograph, 1 Chart, 1 Graph. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22KIDNEY+transplantation%22">KIDNEY transplantation</searchLink><br /><searchLink fieldCode="DE" term="%22QUALITY+of+life%22">QUALITY of life</searchLink><br /><searchLink fieldCode="DE" term="%22MEDICAL+informatics%22">MEDICAL informatics</searchLink><br /><searchLink fieldCode="DE" term="%22MEDICAL+records%22">MEDICAL records</searchLink><br /><searchLink fieldCode="DE" term="%22NEPHROLOGY%22">NEPHROLOGY</searchLink><br /><searchLink fieldCode="DE" term="%22MEDICAL+ethics%22">MEDICAL ethics</searchLink><br /><searchLink fieldCode="DE" term="%22ORGAN+donors%22">ORGAN donors</searchLink> – Name: Abstract Label: Abstract (English) Group: Ab Data: The living donor kidney transplant should be considered a priority option providing better quality of life and survival for those needing renal replacement therapy. To increase their number, both nephrologists and patients, should be informed more and better, offering this option compared with LDKT alternatives (dialysis or kidney transplant from a deceased donor). The clinical nephrology consultations or specific pre-dialysis are the space where in stages 3 and 4 of renal failure should be started on LDKT informational approaches. Later, when seeking more detailed information and/or evaluation of potential donors, this could be provided at times and spaces specifically reserved for awareness professionals with the use of brochures or Internet addresses. Information should focus especially on the additional benefits of pre-emptive LDKT, the risks of nephrectomy and long term controls for the donor. Finally, donor, recipient and family should know that the donation will only be justified and may be accepted if the studies of risk/benefit for the donor and recipient have been faithfully evaluated according to the highest ethical standards. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Abstract (Spanish) Group: Ab Data: El trasplante renal de donante vivo (TRDV) se debe ofrecer como opción terapéutica prioritaria porque proporciona mejores resultados en calidad de vida y supervivencia para quienes precisan tratamiento renal sustitutivo. Para aumentar su número, es preciso informar más y mejor, tanto a nefrólogos como a pacientes, ofreciendo la opción del TRDV junto a las alternativas de tratamiento con diálisis o trasplante renal de donante fallecido. Las consultas de nefrología clínica o las específicas de prediálisis son el espacio donde en estadios 3 y 4 de insuficiencia renal se deben iniciar planteamientos informativos sobre TRDV. Posteriormente, caso de solicitar información más detallada y/o valoración de potenciales donantes, ésta se podría facilitar en momentos y espacios específicamente reservados por profesionales concienciados, siendo de ayuda la utilización de folletos informativos o direcciones de Internet. La información debería incidir especialmente en los beneficios adicionales del TRDV anticipado, los riesgos que supone la intervención de nefrectomía, y los cuidados y controles que necesitará el donante. Finalmente, donante, receptor y familiares deben saber que la donación sólo estará justificada, y podrá ser aceptada, si los estudios de riesgo/beneficio para donante y receptor han sido fielmente evaluados de acuerdo a los mejores estándares éticos. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=57085580 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3265/Nefrologia.pre2010.Nov.10690 Languages: – Code: spa Text: Spanish PhysicalDescription: Pagination: PageCount: 8 StartPage: 39 Subjects: – SubjectFull: KIDNEY transplantation Type: general – SubjectFull: QUALITY of life Type: general – SubjectFull: MEDICAL informatics Type: general – SubjectFull: MEDICAL records Type: general – SubjectFull: NEPHROLOGY Type: general – SubjectFull: MEDICAL ethics Type: general – SubjectFull: ORGAN donors Type: general Titles: – TitleFull: Información a pacientes: cuándo y qué información suministrar. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Frutos, Miguel Ángel – PersonEntity: Name: NameFull: Cabello, Mercedes IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 12 Text: 2010 Type: published Y: 2010 Identifiers: – Type: issn-print Value: 02116995 Numbering: – Type: volume Value: 30 – Type: issue Value: S2 Titles: – TitleFull: Nefrologia Type: main |
| ResultId | 1 |
